NEW YORK, N.Y., February 18, 2004 ? On a visit to his doctor, Gary Jacob received distressing news ? not about himself, but a friend of the doctor's.
While playing with one of his children, the doctor's friend fell and broke a rib. That was bad enough, but during the examination at the hospital, the father was hit with a startling and totally unexpected diagnosis ? he had a disease known as multiple myeloma, a bone marrow blood cancer.
The diagnosis was nothing less than a death sentence.
Jacob knew of the anguish of multiple myeloma patients. The disease is incurable and nearly always fatal, one of the rare diseases that have few, if any, available treatments. They are known as "orphan" diseases, shunned by most drug-makers because the patient populations are small and commercial development of a drug is seen as economically unattractive.
Mr. Jacob was aware because, as Chief Executive Officer of Callisto Pharmaceuticals, Inc., a small Manhattan-based biopharmaceutical company, he is leading a scientific effort to develop a new orphan drug called "Atiprimod" for multiple myeloma patients.
"The father's disease brought home to me that what we are doing is really important," says Mr. Jacob. "Everyone agrees we need more drugs to treat multiple myeloma. There are people out there dying without real hope because of a lack of effective treatment for all patients."
In steadily increasing numbers, orphan drugs are providing new doses of hope where little or none at all existed. In the decade before the inception of the federal Food and Drug Administration's orphan drug program, 10 drugs were developed by pharmaceutical companies for orphan diseases. In the decades since, the FDA says nearly 250 new drugs were developed and approved, and hundreds more are in the pipeline.
Atiprimod is one of those wending its way toward the marketplace. Callisto recently obtained orphan drug designation from the FDA, providing the company with financial incentives to continue the costly development process.
The program covers drugs for orphan diseases with patient populations under 200,000.
The National Organization for Rare Disorders reports about 25 million people in the United States suffer from an estimated 6,000 orphan diseases.
Diseases such as cystic fibrosis, complications affecting HIV-infected people, Gaucher's disease, hemophilia and rare forms of cancer were among the orphans without effective medicines until the FDA program went into effect in 1983 and paved the way for new drugs for patients with these diseases.
Large drug-makers have been largely missing from the efforts.
According to the orphan drug program's deputy director, Dr. John McCormick, only 15% of applications for orphan drug designation have come from the larger pharmaceutical companies.
The reason: expectations of unfavorable investment returns.
The FDA orphan drug incentives ? grants, seven years of marketing exclusivity and tax breaks ? have drawn small pharmaceutical companies with promising drug candidates into the breach.
While the future is brighter, the task is still daunting to develop drugs for orphan diseases.
Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, affects 30,000 Americans with 8,000 new cases diagnosed annually; Huntington's disease also affects about 30,000 patients.
Some diseases affect fewer than 100 patients, according to the National Institutes of Health.
An estimated 50,000 patients have multiple myeloma with 15,000 new patients diagnosed each year. Last year, the FDA approved a new drug Velcade for patients with the disease. However, there are still a number of multiple myeloma patients with no treatment available.
Dr. Kenneth C. Anderson, who played a major role in the preclinical development and clinical trials of Velcade and is now a member of Callisto's Medical Advisory Board, is among the experts who see a need for more drugs to treat multiple myeloma.
"He is excited to see Atiprimod enter clinical trials for evaluation in multiple myeloma patients," Jacob said of Anderson. "He believes it has an opportunity to help patients who have not responded to other drugs. "
Dr. Anderson is director of the Jerome Lipper Multiple Myeloma Center of the Dana-Farber Cancer Institute in Boston, MA, and Professor of Medicine at Harvard Medical School.
The Phase I/IIa trials for Atiprimod are slated to begin later this month.
Dr. Donald Picker, Callisto's Senior Vice President of Drug Development, said studies of Atiprimod in collaboration with scientists at the National Cancer Institute have been very promising.
"In essence, we've shown in these early studies that Atiprimod has the potential to intervene with cancer cells and tumors in three ways ? by inhibiting their formation, by programming their death and by limiting their ability to grow blood vessels necessary for their survival. Taken together, these findings suggest that Atiprimod could potentially represent a novel class of compounds for development for therapeutic intervention in human cancers," said Dr. Picker.
About The Author
Alex Michelini is a former award-winning reporter/editor at the New York Daily News. His credits include nomination for a Pulitzer Prize for a series on medical costs. Among his honors, Mr. Michelini received the Deadline Club Award, the Page One Award, the Associated Press Award and the New York Press Club Award (twice). He is the founder of Alex Michelini Public Relations, and has developed and collaborated on articles appearing in the New York Times, the Wall Street Journal, the London Times, the New York Post, the New York Daily News, Bloomberg Radio & TV, CNNfn, WCBS Radio & TV. WINS radio, the Christian Science Monitor, Fox TV, Reuters, Newsday and other media outlets.
|
|
|
|
|
|
|
|
|
|
|


Lunesta is a newly released sleeping pill. Marketed as a... Read More
Throughout time there have always been two opposing points of... Read More
Quality, dependable Medical Equipment is an important component of every... Read More
Bextra, also known as valdecoxib, is a prescription... Read More
GET TO KNOW YOUR ARTHRITISArthritis is referred to as the... Read More
When was the last time you enjoyed a good night's... Read More
I stumbled across TMJ when I needed treat a literal... Read More
Tea tree oil is the essential oil comes from the... Read More
It is very interesting this hypochondriac attitude which permeates our... Read More
Technology. We live in a grand time of technological development.... Read More
Medical Billing PDAOne of the first things I notice about... Read More
When diversifying an investment portfolio, one needs to consider investing... Read More
As a physician specializing in psychiatry, I know that many... Read More
Pill Proof LLC introduces the first, easy to use medication... Read More
It was around 1986, when my son Lewis was diagnosed... Read More
When was the last time you enjoyed a good night's... Read More
Hi Rusty. A few days ago, I slightly injured a... Read More
The FDA (Food and Drug Administration) is responsible for overseeing... Read More
Cybill Shepherd has revealed that she suffers from irritable bowel... Read More
Checklist of Treatments for Alzheimer's DiseasePart 3 of 83. Three... Read More
All medications, which include prescriptions, over-the-counter preparations, vitamin and mineral... Read More
One of the most prevalent and difficult health conditions to... Read More
Individuals who regularly take Relafen (nabumetone) or other anti-inflammatory medications,... Read More
You've been getting headaches. Finally, you find some medications that... Read More
Hypnotherapy is one of the best known and most widely... Read More
Prescription drugs can save your life. But interactions between prescription... Read More
Gout, an arthritis affliction with its roots in antiquity, has... Read More
Viga and Viga for Women is a dietary supplement sold... Read More
Using ice to treat injuries is one of the oldest... Read More
Molluscum contagiosum treatment is certainly possible with the correct treatment... Read More
The American Heart Association estimates that one of three Americans... Read More
The most common cause of heel pain is plantar fasciitis... Read More
The news has been full of the recent FDA findings... Read More


There has definitely been a good deal of controversy over... Read More
Addictions come in many forms. It's important to recognize the... Read More
What's Insomnia?Identifying insomnia is a little like the old joke... Read More
1. Online Canadian pharmacies offer overall best prices on Canadian... Read More
Myth #1: "Nothing can be done about arthritis..."You don't have... Read More
America's war on drugs, which has been fought in the... Read More
As computers, Internet and technology have become increasingly more available... Read More
In September, 2004, pharmaceutical giant Merck voluntarily withdrew its painkilling... Read More
Perhaps one of the most insidious dangers in modern technology... Read More
Zoloft is an SSRI (selective serotonin reuptake inhibitor); a prescription... Read More
For the head of the trauma department at one of... Read More
Warning: This article is for information only and can not... Read More
High blood pressure is on the rise worldwide. But, doctors... Read More
Remember the last time you stubbed your toe? OUCH! It's... Read More
You probably know the drug isotretinoin by its trade name,... Read More
Q. Why is there so may uninsured people in America?A.... Read More
How many of us have taken aspirin or a similar... Read More
We've all had garden variety headaches from time to time.... Read More
Online Pharmacy owners who haven't been working within moral and... Read More
The recent withdrawal of Vioxx and Bextra from the marketplace,... Read More
When you search online for Electric Wheelchairs, like any other... Read More
Tendons are ropes of fibrous tissue that connect muscles to... Read More
I stumbled across TMJ when I needed treat a literal... Read More
In patients with corneal thickness below a certain minimum, performing... Read More
Every year about this time doctors around the world are... Read More
Throughout time there have always been two opposing points of... Read More
Are you frustrated with the high prices of prescription drugs?... Read More
For many years since medicine has been established as an... Read More
The news has been full of the recent FDA findings... Read More
It just seemed too absurd to be true, but there... Read More
Lunesta is a newly released sleeping pill. Marketed as a... Read More
Healthcare professionals are under pressure to remember, utilize and absorb... Read More
Marketing Authorisation: Medicinal Products The case of R (on the... Read More
Medicine |